Bufatas IV 6mg Injection

Overview Bufatas IV 6mg Injection

Bufatalin 6mg intravenous injection is indicated in the management of certain hematologic malignancies, notably chronic myelogenous leukemia. It's administered alongside other antineoplastic agents during hematopoietic stem cell transplantation (HSCT). Off-label applications in other cancers may also exist. Administration is intravenous, exclusively by a healthcare professional, with dosage and regimen tailored to the specific indication and subject to modification. Adherence to the prescribed course is crucial; improper use or overdose can lead to severe adverse effects. Therapeutic benefits may not be immediately apparent, often taking weeks or months to manifest. Discontinuation should only occur under medical supervision. Frequently reported adverse events include cytopenia (affecting red blood cells, white blood cells, and platelets), nausea, emesis, and anorexia. Report any concerning symptoms to your physician; mitigating strategies may be available. Pre-existing conditions, including bleeding disorders, hepatic or cardiac dysfunction, prior radiation therapy, and infections, should be disclosed. Significant drug interactions are possible; comprehensive medication disclosure to your doctor is essential. Seek immediate medical attention for symptoms suggesting bleeding complications (excessive bruising, hematochezia, melena), or signs of infection (sore throat). Bufatalin’s myelosuppressive effect increases infection risk, necessitating regular blood counts, along with renal, hepatic, and cardiac function monitoring. Effective contraception is recommended for both partners during treatment to prevent conception.

Uses of Bufatas IV 6mg Injection

Chronic myelogenous leukemia, a type of blood malignancy.

Major Benefits of Bufatas IV 6mg Injection:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

Common Side effects of Bufatas IV 6mg Injection:

• Decreased blood cells (red cells, white cells, and platelets)
• Nausea
• Abdominal pain
• Vomiting
• Loss of appetite
• Anxiety
• Decreased magnesium level in blood
• Decreased potassium level in blood
• Diarrhea
• Fever
• Headache
• Increased glucose level in blood
• Insomnia (difficulty in sleeping)
• Stomatitis (Inflammation of the mouth)

How to use Bufatas IV 6mg Injection:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

How Bufatas IV 6mg Injection works:

Oncolysin-6 injection (6mg) is a cancer treatment that disrupts the genetic structure (DNA and RNA) within cancerous cells, thereby halting their proliferation.

What if you forget to take Bufatas IV 6mg Injection :

Should you forget a dose of Bufatas IV 6mg Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.